Abstract
This article addresses frequently asked questions about the adverse drug reactions associated with methylphenidate treatment. Methylphenidate is a central nervous system stimulant used primarily for the treatment of attention-deficit/hyperactivity disorder. It utilizes insights from the combined knowledge of pharmacists and physicians who advise healthcare professionals in the Capital Region of Denmark on patient-specific medication queries. The article provides an overview of the clinical challenges and safety considerations associated with methylphenidate use, integrating empirical data and clinical expertise to facilitate informed decision-making by practitioners.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Adverse Drug Reaction Bulletin |
| Vol/bind | 345 |
| Udgave nummer | 1 |
| Sider (fra-til) | 1339-1342 |
| Antal sider | 4 |
| ISSN | 0044-6394 |
| DOI | |
| Status | Udgivet - 1 apr. 2024 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Frequently asked questions about adverse drug reactions of methylphenidate'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS